Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation

Laura J Gray, Kamlesh Khunti, Sian Williams, Stephanie Goldby, Jacqui Troughton, Thomas Yates, Alastair Gray, Melanie J Davies, Let's Prevent Collaborators, A Farooqi, M Carey, K Abrams, T Skinner, J Tuomilehto, S Heller, N Samani, B Stribling, K Jones, Laura J Gray, Kamlesh Khunti, Sian Williams, Stephanie Goldby, Jacqui Troughton, Thomas Yates, Alastair Gray, Melanie J Davies, Let's Prevent Collaborators, A Farooqi, M Carey, K Abrams, T Skinner, J Tuomilehto, S Heller, N Samani, B Stribling, K Jones

Abstract

Background: The prevention of type 2 diabetes is a globally recognised health care priority, but there is a lack of rigorous research investigating optimal methods of translating diabetes prevention programmes, based on the promotion of a healthy lifestyle, into routine primary care. The aim of the study is to establish whether a pragmatic structured education programme targeting lifestyle and behaviour change in conjunction with motivational maintenance via the telephone can reduce the incidence of type 2 diabetes in people with impaired glucose regulation (a composite of impaired glucose tolerance and/or impaired fasting glucose) identified through a validated risk score screening programme in primary care.

Design: Cluster randomised controlled trial undertaken at the level of primary care practices. Follow-up will be conducted at 12, 24 and 36 months. The primary outcome is the incidence of type 2 diabetes. Secondary outcomes include changes in HbA1c, blood glucose levels, cardiovascular risk, the presence of the Metabolic Syndrome and the cost-effectiveness of the intervention.

Methods: The study consists of screening and intervention phases within 44 general practices coordinated from a single academic research centre. Those at high risk of impaired glucose regulation or type 2 diabetes are identified using a risk score and invited for screening using a 75 g-oral glucose tolerance test. Those with screen detected impaired glucose regulation will be invited to take part in the trial. Practices will be randomised to standard care or the intensive arm. Participants from intensive arm practices will receive a structured education programme with motivational maintenance via the telephone and annual refresher sessions. The study will run from 2009-2014.

Discussion: This study will provide new evidence surrounding the long-term effectiveness of a diabetes prevention programme conducted within routine primary care in the United Kingdom.

Trial registration: Clinicaltrials.gov NCT00677937.

Figures

Figure 1
Figure 1
Study participation.

References

    1. Kuznik A, Mardekian J. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999–2008. Cardiovasc Diabetol. 2011;10:31. doi: 10.1186/1475-2840-10-31.
    1. World Health Organization. global health risks: mortality and burden of disease attributable to selected major risk factors. World Health Organization, Geneva; 2009.
    1. Zhang P. et al.Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:293–301. doi: 10.1016/j.diabres.2010.01.026.
    1. Khunti K. et al.Unanswered questions over NHS health checks. BMJ. 2011;342:316–318. doi: 10.1136/bmj.d316.
    1. Gillies CL. et al.Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334:299. doi: 10.1136/bmj.39063.689375.55.
    1. Lauritzen T, Borch-Johnsen K, Sandbaek A. Is prevention of type 2 diabetes feasible and efficient in primary care? A systematic PubMed review. Prim Care Diabetes. 2007;1:5–11. doi: 10.1016/j.pcd.2006.11.001.
    1. Yates T, Khunti K, Davies MJ. Prevention of diabetes: a reality in primary care? Prim Care Diabetes. 2007;1:119–121. doi: 10.1016/j.pcd.2007.07.003.
    1. Absetz P. et al.Type 2 diabetes prevention in the "real world: three-year results of the GOAL Implementation Trial. Diabetes Care. 2009;32:1418–1420. doi: 10.2337/dc09-0039.
    1. Ackermann RT. et al.Translating the diabetes prevention program into the community: the deploy pilot study. Am J Prev Med. 2008;35:357–63. doi: 10.1016/j.amepre.2008.06.035.
    1. Laatikainen T. et al.Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health. 2007;7:249. doi: 10.1186/1471-2458-7-249.
    1. Schwarz PE. et al.Development of a diabetes prevention management program for clinical practice. Public Health Rep. 200;122:258–263.
    1. Yates T. et al.Effectiveness of a pragmatic education programme aimed at promoting walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care. 2009;32:1404–10. doi: 10.2337/dc09-0130.
    1. Yates T. et al.The Prediabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at two years? Diabet Med. 2011;10:1268–1271.
    1. Excellence., N.I.f.H.a.C. Type 2 diabetes: National clinical guideline for management in primary and secondary care (update) Royal Collage of Physicians, London; 2008.
    1. UK., D.o.H.D. Structured patient education in diabetes: Report from the Patient Education Working Group. Department of Health, London; 2005.
    1. Gillett M. et al.Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ. 2010;341:c4093. doi: 10.1136/bmj.c4093.
    1. Waugh N. et al.Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess. 2007;11(17):1–125.
    1. Eborall H. et al.Influences on the uptake of diabetes screening: a qualitative study in primary care. Br J Gen Pract. 2012;62(596):e204–11. doi: 10.3399/bjgp12X630106.
    1. Webb DR. et al.Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia. 2011;54(9):2237–46. doi: 10.1007/s00125-011-2189-2.
    1. Goyder E, National evaluation of DHDS Diabetes Screening Pilot Programme. Final Report. School of Health and Related Research, University of Sheffield; 2008.
    1. Sargeant LA. et al.Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study. Diabet Med. 2010;27(9):995–1003. doi: 10.1111/j.1464-5491.2010.03056.x.
    1. Schwarz P, Non-pharmacological intervention for diabetes mellitus prevention in populations: Where do we stand. Nat Rev Endocrinol. 2012.
    1. Collins GS. et al.Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011;9:103. doi: 10.1186/1741-7015-9-103.
    1. Gray LJ. et al.Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia. 2012;55(4):959–996. doi: 10.1007/s00125-011-2432-x.
    1. World Health Organisation. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organisation, Geneva; 1999.
    1. Office of the Deputy Prime Minister. The English Indices of Deprivation 2007 (Revised) ODPM Publications, London; 2007. webcite and 2007.
    1. Roe L. et al.Dietary intervention in primary care: Validity of the DINE method for diet assessment. Fam Pract. 1994;11:375–381. doi: 10.1093/fampra/11.4.375.
    1. Sintonen H, Pekurinen M, In: Quality of Life Assessment: Key Issues in the 1990s. Walker SR, editor. Kluver Academic Publishers, Dordrecht; 1992. A fifteen-dimensional measure of health-related quality of life (15D) and its applications. Kirjassa; pp. 185–195.
    1. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand. 2006;67:361–70.
    1. Broadbent E. et al.The brief illness perception questionnaire. J Psychosom Res. 2006;60:631–637. doi: 10.1016/j.jpsychores.2005.10.020.
    1. Craig CL. et al.International physical activity questionnaire: 12-country reliability and validity. Medicine and science in sports and exercise. 2003;35:1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB.
    1. Kita T. et al.Short sleep duration and poor sleep quality increase the risk of diabetes in Japanese workers with no family history of diabetes. Diabetes Care. 2012;35(2):313–8. doi: 10.2337/dc11-1455.
    1. Craig P. et al.Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655.
    1. Frei A. et al.The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial. Cardiovascular Diabetology. 2010;9 doi: 10.1186/1475-2840-9-23.
    1. Shah BR. et al.Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial. Trials. 2010;11:44. doi: 10.1186/1745-6215-11-44.
    1. Jansink R. et al.Nurse-led motivational interviewing to change the lifestyle of patients with type 2 diabetes (MILD-project): protocol for a cluster, randomized, controlled trial on implementing lifestyle recommendations. BMC Health Serv Res. 2009;9:19. doi: 10.1186/1472-6963-9-19.
    1. Webb D. et al.Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials. 2010;19(11):16.
    1. Kind P. et al.Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998;316:736–741. doi: 10.1136/bmj.316.7133.736.
    1. Leventhal H, Meyer D, Nerenz D. In: Medical psychology (Vol II, pp.7-30) Rachman S, editor. Pergamon Press, New York; 1980. The common sense representation of illness danger.
    1. Chaiken S. In: The Ontario symposium. Zanna MP, Olson JM, Herman CP, editor. Erlbaum, Hillsdale; 1987. The Heuristic model of persuasion, in Social influence; pp. 3–39.
    1. Bandura A. Self-efficacy: The exercise of control. W.H. Freeman, New York; 1997.
    1. Gollwitzer PM. Implementation intentions: strong effects of simple plans:How can good intentions become effective behaviour change strategies? American Psychologist. 1999;54:493–503.
    1. Funnell MM. et al.Empowerment: an idea whose time has come in diabetes education. Diabetes Educator. 1992;17:37–41.
    1. Diabetes Prevention Programme Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intrevention and metformin. New ENgland Journal of Medicine. 2002;346:393–403.
    1. Tuomilehto J. et al.Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England journal of medicine. 2001;344(18):1343–1350. doi: 10.1056/NEJM200105033441801.
    1. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, Dallosso HM, Daly H, Doherty Y, Eaton S, Fox C, Oliver L, Rantell K, Rayman G, Khunti K. on behalf of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. British Medical Journal. 2008;336:491–495. doi: 10.1136/.
    1. Stone M. et al.Using qualitative research methods to inform the development of a modified version of a patient education module for non English speakers with type 2 diabetes: experiences from an action research project on two south asian populations in the UK. Diversity in health and Social Care. 2008;3:199–206.
    1. D'Agostino RB. et al.Validation of the framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180–7. doi: 10.1001/jama.286.2.180.
    1. Expert Panel On Detection. E., And Treatment Of High Blood Cholesterol In Adults,, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–97. doi: 10.1001/jama.285.19.2486.
    1. Ramachandran A. et al.The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia. 2006;49(2):289–297. doi: 10.1007/s00125-005-0097-z.
    1. Lindström J. et al.The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–6. doi: 10.2337/diacare.26.12.3230.
    1. Yamaoka K, Tango T. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 2005;28:2780–2786. doi: 10.2337/diacare.28.11.2780.
    1. Yates T. et al.The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia. 2007;50:1116–1126. doi: 10.1007/s00125-007-0638-8.
    1. Campbell MK, Elbourne DR ADG. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328(7441):702–708. doi: 10.1136/bmj.328.7441.702.
    1. Paulweber B. et al.A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res. 2010;42(Suppl. 1):42.
    1. Programme TD.
    1. Walker N. et al.The vascular risk assessment programme: implications for the delivery in primary care. Diabetes and Primary Care. 2009;11:4.
    1. National Institute for Health and Clinical Excellence. Public Health Draft Guidence, Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. National Institute for Health and Clinical Excellence, London; 2011.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren